Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized doubl...
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
About this item
Full title
Author / Creator
Zhang, Mei , Liu, Yan , Xu, Mingjun , Zhang, Lei , Liu, Xiaoling , Zhao, Yuxia , Zhu, Fang , Xu, Rui , Ou, Zhihong , Wang, Ying , Liu, Qigong , Ma, Shuping , Wang, Tian , He, Maolin , Lu, Qinghua , Li, Honghua , Huang, Jihan and Zhang, Yun
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
To determine whether the traditional Chinese medicine Tongxinluo (TXL) is efficacious at retarding the progression of carotid atherosclerotic lesions, a total of 1,212 patients with a focal intima-media thickness (IMT) of ≥1.2 mm of the carotid arteries received TXL or placebo capsules in addition to current routine therapy. The primary outcome was...
Alternative Titles
Full title
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6418108
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6418108
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-019-41118-z
